专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2012148003A1 ANTI-HUMAN RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE σ ANTIBODY 审中-公开
标题翻译：抗人受体型蛋白酪氨酸磷酸酶抗体
公开(公告)号：WO2012148003A1
公开(公告)日：2012-11-01
申请号：PCT/JP2012/061795
申请日：2012-04-27
申请人： SBI BIOTECH CO., LTD. , YAMAZAKI, Tomohide , ZHAO, Jing , ISHIDA, Koji , SHIBATA, Yasue , CHO, Minkwon , ENDO, Mayuki
发明人： YAMAZAKI, Tomohide , ZHAO, Jing , ISHIDA, Koji , SHIBATA, Yasue , CHO, Minkwon , ENDO, Mayuki
IPC分类号： G01N33/68 , C07K16/28 , A61K39/395
CPC分类号： C07K16/40 , C07K16/2803 , C07K2317/24 , C07K2317/33 , C07K2317/732 , C07K2317/734 , C07K2317/76 , G01N33/5058 , G01N33/56972
摘要： A monoclonal antibody that binds to an extracellular domain of human receptor-type protein tyrosine phosphatase σ (human PTPRS), or a fragment including an antigen-binding region thereof.
摘要翻译：结合人受体型蛋白酪氨酸磷酸酶（人PTPRS）的细胞外结构域的单克隆抗体或包含其抗原结合区的片段。

2. 发明授权

EP3232202B1 ANTI-HUMAN RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE ANTIBODY 有权转让
公开(公告)号：EP3232202B1
公开(公告)日：2020-02-19
申请号：EP17174348.7
申请日：2012-04-27
申请人： SBI Biotech Co., Ltd.
发明人： YAMAZAKI, Tomohide , ZHAO, Jing , ISHIDA, Koji , SHIBATA, Yasue , CHO, Minkwon , ENDO, Mayuki
IPC分类号： G01N33/68 , C07K16/28 , A61K39/395

3. 发明公开

EP3232202A1 ANTI-HUMAN RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE ANTIBODY 有权转让
标题翻译：抗人受体型蛋白酪氨酸磷酸酶抗体
公开(公告)号：EP3232202A1
公开(公告)日：2017-10-18
申请号：EP17174348.7
申请日：2012-04-27
申请人： SBI Biotech Co., Ltd.
发明人： YAMAZAKI, Tomohide , ZHAO, Jing , ISHIDA, Koji , SHIBATA, Yasue , CHO, Minkwon , ENDO, Mayuki
IPC分类号： G01N33/68 , C07K16/28 , A61K39/395
摘要： A monoclonal antibody that binds to an extracellular domain of human receptor-type protein tryosine phosphatase σ (human PTPRS), or a fragment including an antigen-binding region thereof.
摘要翻译：结合人受体型蛋白质酪氨酸磷酸酶σ（人PTPRS）的胞外结构域的单克隆抗体或包含其抗原结合区的片段。

4. 发明授权

EP2702412B1 ANTI-HUMAN RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE ANTIBODY 有权转让
标题翻译：抗人受体型蛋白酪氨酸磷酸酶抗体
公开(公告)号：EP2702412B1
公开(公告)日：2017-07-26
申请号：EP12722557.1
申请日：2012-04-27
申请人： SBI Biotech Co., Ltd.
发明人： YAMAZAKI, Tomohide , ZHAO, Jing , ISHIDA, Koji , SHIBATA, Yasue , CHO, Minkwon , ENDO, Mayuki
IPC分类号： G01N33/68 , C07K16/28 , A61K39/395
CPC分类号： C07K16/40 , C07K16/2803 , C07K2317/24 , C07K2317/33 , C07K2317/732 , C07K2317/734 , C07K2317/76 , G01N33/5058 , G01N33/56972

5. 发明公开

EP2702412A1 ANTI-HUMAN RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE ANTIBODY 有权转让
标题翻译：抗生素GEGEN人类复苏 - 蛋白磷酸化酶
公开(公告)号：EP2702412A1
公开(公告)日：2014-03-05
申请号：EP12722557.1
申请日：2012-04-27
申请人： SBI Biotech Co., Ltd.
发明人： YAMAZAKI, Tomohide , ZHAO, Jing , ISHIDA, Koji , SHIBATA, Yasue , CHO, Minkwon , ENDO, Mayuki
IPC分类号： G01N33/68 , C07K16/28 , A61K39/395
CPC分类号： C07K16/40 , C07K16/2803 , C07K2317/24 , C07K2317/33 , C07K2317/732 , C07K2317/734 , C07K2317/76 , G01N33/5058 , G01N33/56972
摘要： A monoclonal antibody that binds to an extracellular domain of human receptor-type protein tyrosine phosphatase σ (human PTPRS), or a fragment including an antigen-binding region thereof.
摘要翻译：结合人受体型蛋白酪氨酸磷酸酶的细胞外结构域的单克隆抗体（人PTPRS）或包含其抗原结合区的片段。

6. 发明申请

WO2013185300A1 OBTAINING ALTERNATIVE KEYWORDS 审中-公开
标题翻译：获得替代关键词
公开(公告)号：WO2013185300A1
公开(公告)日：2013-12-19
申请号：PCT/CN2012/076804
申请日：2012-06-12
申请人： GOOGLE INC. , LUI, Ka Cheong , ZHAO, Jing
发明人： LUI, Ka Cheong , ZHAO, Jing
IPC分类号： G06F17/30
CPC分类号： G06Q30/0256 , G06F17/3053 , G06F17/30598 , G06F17/30616
摘要： A system includes receiving information regarding a first keyword associated with a user, where the first keyword is usable by a content distribution system to select content for distribution based on keywords associated with the user. The system also includes obtaining an attribute associated with the user; identifying at least one keyword category corresponding to the attribute; and selecting at least one alternative keyword associated with the at least one identified keyword category. The selecting may include consulting a taxonomy database to identify alternative keywords that are relevant to the first keyword. The system also includes ranking the at least one alternative keyword according to a ranking rule associated with the at least one keyword category associated with the at least one alternative keyword; and providing information associated with the ranked at least one alternative keyword to the user for selection by the user.
摘要翻译：系统包括接收关于与用户相关联的第一关键字的信息，其中第一关键词可由内容分发系统使用以基于与用户相关联的关键词选择分发内容。该系统还包括获得与用户相关联的属性; 识别对应于该属性的至少一个关键字类别; 以及选择与所述至少一个所识别的关键字类别相关联的至少一个替代关键字。选择可以包括咨询分类数据库以识别与第一关键字相关的备选关键字。该系统还包括根据与至少一个替代关键字相关联的至少一个关键字类别相关联的排序规则对至少一个备选关键字进行排名; 以及向所述用户提供与所述排序的至少一个备选关键字相关联的信息以供所述用户选择。

7. 发明申请

WO2010124561A1 MICROPHONE 审中-公开
标题翻译：麦克风
公开(公告)号：WO2010124561A1
公开(公告)日：2010-11-04
申请号：PCT/CN2010/071861
申请日：2010-04-17
申请人： BYD COMPANY LIMITED , ZHAO, Jing , YANG, Gangjian , XU, Kunping , LI, Hai , YANG, Yun , FENG, Wei
发明人： ZHAO, Jing , YANG, Gangjian , XU, Kunping , LI, Hai , YANG, Yun , FENG, Wei
IPC分类号： H04R1/00
CPC分类号： H04R19/005 , H04R19/016 , H04R2410/03
摘要： The present invention discloses a microphone, which may comprise an inner unit comprising a microphone module; a driver module coupled to the microphone module; a noise cancellation module coupled to the driver module; and a housing for accommodating the inner unit. At least two modules selected from the microphone module, the driver module and the noise cancellation module may be integrated in a chip. The microphone according to the present invention has a smaller volume with reduced technical complexity.
摘要翻译：本发明公开了一种麦克风，其可以包括包括麦克风模块的内部单元; 耦合到所述麦克风模块的驱动器模块; 耦合到所述驱动器模块的噪声消除模块; 以及用于容纳内部单元的壳体。从麦克风模块，驱动器模块和噪声消除模块中选择的至少两个模块可以集成在芯片中。根据本发明的麦克风具有较小的体积，降低了技术复杂性。

8. 发明申请

WO2010022328A2 GENETIC LOCI ASSOCIATED WITH HEAD SMUT RESISTANCE IN MAIZE 审中-公开
标题翻译：玉米幼穗抗褐飞虱遗传基础研究
公开(公告)号：WO2010022328A2
公开(公告)日：2010-02-25
申请号：PCT/US2009/054609
申请日：2009-08-21
申请人： E. I. DU PONT DE NEMOURS AND COMPANY , XU, Mingliang , LI, Bailin , FENGLER, Kevin , CHAO, Qing , CHEN, Yongsheng , ZHAO, Xianrong , ZHAO, Jing
发明人： XU, Mingliang , LI, Bailin , FENGLER, Kevin , CHAO, Qing , CHEN, Yongsheng , ZHAO, Xianrong , ZHAO, Jing
IPC分类号： C12Q1/68
CPC分类号： C12N15/8282 , C07K14/415 , C12Q1/6895 , C12Q2600/156 , G01N33/56961
摘要： Head smut is one of the most devastating diseases in maize, causing severe yield loss worldwide. The present invention describes the fine-mapping of a major QTL conferring resistance to head smut. Markers useful for breeding, and methods for conferring head smut resistance are described. Nucleic acid sequence from the genetic locus conferring head smut resistance is disclosed. Genes encoding proteins conferring head smut resistance are disclosed.
摘要翻译：黑穗病是玉米中最具破坏性的疾病之一，导致全球严重的产量损失。本发明描述了赋予针对黑穗病的抗性的主要QTL的精细作图。描述了用于育种的标记以及赋予抗黑斑病抗性的方法。公开了赋予头部抗污染性的来自遗传基因座的核酸序列。公开了编码赋予头部抗污染性的蛋白质的基因。

9. 发明申请

WO2015171209A1 CARBON FIBER COMPOSITE SPRINGS AND METHOD OF MAKING THEREOF 审中-公开
标题翻译：碳纤维复合弹簧及其制造方法
公开(公告)号：WO2015171209A1
公开(公告)日：2015-11-12
申请号：PCT/US2015/021872
申请日：2015-03-20
申请人： ZHAO, Jing
发明人： ZHAO, Jing
IPC分类号： F16F1/18 , A43B13/18
CPC分类号： F16F1/368 , A42B3/064 , A42B3/124 , A43B13/183 , A43B13/184 , A47C7/025
摘要： A bow shaped, sheet-thin, carbon fiber spring that utilizes the material's special characteristics is disclosed. Carbon fiber filaments are laid along the bow curvature. Cushions made of carbon fiber composite springs provide performance improvements in better shock absorption, lighter weight, better fire safety, and longer life without performance degradation. Example embodiments are shoes, helmets, and seats.
摘要翻译：公开了一种利用材料特殊特性的弓形薄板碳纤维弹簧。碳纤维丝沿弓曲率铺设。由碳纤维复合弹簧制成的靠垫提供更好的减震性能，更轻的重量，更好的消防安全性能和更长的使用寿命，而不会降低性能。示例性实施例是鞋，头盔和座椅。

10. 发明申请

WO2021061719A1 METHODS FOR TREATING METASTATIC TRIPLE NEGATIVE BREAST CANCER WITH ANTI-PD-1 ANTIBODIES 审中-公开
公开(公告)号：WO2021061719A1
公开(公告)日：2021-04-01
申请号：PCT/US2020/052141
申请日：2020-09-23
申请人： MERCK SHARP & DOHME CORP. , AKTAN, Gursel , DANSEY, Roger Delemere , KARANTZA, Vassiliki , GUO, Zifang , MEJIA, Jaime, A. , SU, Shu-Chih , ZHAO, Jing , ZHOU, Xuan
发明人： AKTAN, Gursel , DANSEY, Roger Delemere , KARANTZA, Vassiliki , GUO, Zifang , MEJIA, Jaime, A. , SU, Shu-Chih , ZHAO, Jing , ZHOU, Xuan
IPC分类号： A61K39/395 , A61K31/506 , A61P35/00
摘要： The present invention relates to methods for treating metastatic triple negative breast cancer in a human patient which has been identified as having a PD-L1 enriched tumor comprising administering, as monotherapy, an anti-PD-1 antibody or antigen binding fragment thereof (e.g., pembrolizumab) in specific amounts to the patient about every three or six weeks, wherein the PD-L1 enriched tumor is a tumor identified as having a CPS score of ≥ 10.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式